Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Does physician specialty affect persistence to pharmacotherapy among patients with overactive bladder syndrome?
Mirikizumab Sustained Impact on Fatigue in Patients with Moderately to Severely Active Crohn's Disease in the Phase 2 AMAG Study.
Recommendations for Standardizing Clinical Trial Design and Endoscopic Assessment in Postoperative Crohn's Disease.
Worldwide post-marketing safety surveillance experience with tofacitinib in ulcerative colitis.
hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma.
hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma. Cancer Res. 2010 Mar 01; 70(5):1916-24.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Asbestos
Cell Line, Tumor
Female
Humans
Male
Mesothelioma
MicroRNAs
Middle Aged
Pleural Neoplasms
Prognosis
Reproducibility of Results
Reverse Transcriptase Polymerase Chain Reaction
Transfection
authors with profiles
Jessica Donington